Text: Aviva plc Annual report and accounts 2005

Notes to the consolidated financial statements 1-10

1 – First time adoption of International Financial Reporting Standards

(a) The Group has adopted International Financial Reporting Standards (IFRS) for these financial statements for the year ended 31 December 2005. In order to show comparative balances, the year ended 31 December 2004 is also shown under IFRS. The date of transition to IFRS is 1 January 2004.

In general, a company is required to determine its IFRS accounting policies and apply these retrospectively to determine its opening balance sheet under IFRS. However, International Financial Reporting Standard 1, First time adoption of International Financial Reporting Standards, (IFRS 1) allows a number of exemptions to this general principle upon adoption of IFRS. The Group has taken advantage of the following transitional arrangements.

Business combinations

The Group has elected not to apply retrospectively the provisions of IFRS 3, Business Combinations, to business combinations that occurred prior to 1 January 2004. At the date of transition, no adjustment was made between UK GAAP and IFRS for any historical business combination.

Cumulative translation differences

The Group has elected that the cumulative translation differences of foreign operations were deemed to be zero at the transition date to IFRS.

Equity compensation plans

The Group has elected not to apply the provisions of IFRS 2, Share-based Payment, to options and awards granted on or before 7 November 2002 which had not vested by 1 January 2005.

Employee benefits

All cumulative actuarial gains and losses on the Group’s defined benefit pension schemes have been recognised in equity at the transition date.

Comparatives

The Group has not taken advantage of the exemption within IFRS 1 that allows comparative information presented in the first year of adoption of IFRS not to comply with IAS 32, Financial Instruments: Disclosure and Presentation, IAS 39, Financial Instruments: Recognition and Measurement and IFRS 4, Insurance Contracts.

Estimates

Where estimates had previously been made under UK GAAP, consistent estimates (after adjustments to reflect any difference in accounting policies) have been made for the same date on transition to IFRS (ie judgements affecting the Group’s opening balance sheet have not been revisited for the benefit of hindsight).

Held for sale

The requirements of International Financial Reporting Standard 5, Non-current Assets Held for Sale and Discontinued Operations, have been applied prospectively from 1 January 2005.

Transitional provisions

The Group has elected to disclose only five years of data in its loss development tables, as permitted by IFRS 4 in the year of adoption of IFRS. This will be increased in each succeeding additional year, until the full ten years of information is included.

(b) The following tables show the effect of adopting IFRS on the statements that have previously been reported under UK GAAP for the year ending 31 December 2004. They also show the effect of implementing FRS 27, Life Assurance, and of changing the methodology for the Group’s longer term investment return.

(i) Summarised consolidated balance sheet at date of transition to IFRS – 1 January 2004

  UK GAAP
as published
£m
  Adjustments
£m
IFRS
£m
Assets      
Goodwill 1,105 40 1,145
Acquired value of in-force business and intangible assets 488 488
Investments in joint ventures and associates 1,912 69 1,981
Property and equipment 320 563 883
Investment property 9,106 618 9,724
Financial investments and loans 129,032 40,518  169,550
Assets held to cover linked liabilities 40,665 (40,665)
Reinsurance assets 6,883 328 7,211
Tax assets 215 633 848
Other assets 15,955 (3,610) 12,345
Cash and cash equivalents 2,999 6,524 9,523
Total assets 208,680 5,018  213,698
Equity      
Share capital 764 764
Capital reserves 3,859 3,859
Shares held by employee trusts (1) (1)
Revaluation and other reserves 543 543
Retained earnings 1,932 (877) 1,055
Equity attributable to shareholders of Aviva plc 6,554 (334) 6,220
Minority interests 811 (7) 804
Total equity 7,365 (341) 7,024
Liabilities      
Insurance liabilities 175,304 (62,055) 113,249
Liability for investment contracts 57,467 57,467
Unallocated divisible surplus 8,443 1,650 10,093
Net asset value attributable to unitholders 1,606 1,606
Provisions 336 1,586 1,922
Tax liabilities 1,276 630 1,906
Borrowings (including subordinated debt) 4,722 3,645 8,367
Other liabilities 11,234 830 12,064
Total liabilities 201,315 5,359 206,674
Total equity and liabilities 208,680 5,018  213,698

Analysis of adjustments to the balance sheet at 1 January 2004 as a result of the transition to IFRS

  Investment
valuation
(note 1)
£m
Insurance
changes
(note 2)
£m
Employee
benefits
(note 3)
£m
Goodwill
(note 4)
£m
Dividend
recognition
(note 5)
£m
Deferred tax
(note 6)
£m
Borrowings/
cash
(note 7)
£m
Other items
(note 9)
£m
Total
adjustments
£m
Assets                  
Goodwill       40         40
Acquired value of in-force business and intangible assets                
Investments in joint ventures and associates 7             62 69
Property and equipment               563 563
Investment property               618 618
Financial investments and loans 1,854           44 38,620 40,518
Assets held to cover linked liabilities               (40,665) (40,665)
Reinsurance assets   (134)           462 328
Tax assets           617   16 633
Other assets   (36) (427)       67 (3,214) (3,610)
Cash and cash equivalents             3,547 2,977 6,524
Total assets 1,861 (170) (427) 40 617 3,658 (561) 5,018
Equity                  
Share capital                
Capital reserves                
Revaluation and other reserves 543               543
Retained earnings (352) 242 (834) 40 344 (351) (37) 71 (877)
                   
Equity attributable to shareholders of Aviva plc 191 242 (834) 40 344 (351) (37) 71 (334)
Minority interests               (7) (7)
Total equity 191 242 (834) 40 344 (351) (37) 64 (341)
Liabilities                  
Insurance liabilities 161 (57,892) (715)     58   (3,667) (62, 055)
Liability for investment contracts   57,445           22 57,467
Unallocated divisible surplus 1,509 (79)       (48)   268 1,650
Net asset value attributable to unitholders               1,606 1,606
Provisions     1,475         111 1,586
Tax liabilities   14 (353)     958 (15) 26 630
Borrowings (including subordinated debt)             3,484 161 3,645
Other liabilities   100     (344)   226 848 830
Total liabilities 1,670 (412) 407 (344) 968 3,695 (625) 5,359
Total equity and liabilities 1,861 (170) (427) 40 617 3,658 (561) 5,018

Note references are to section (iii)

(ii) Summarised consolidated balance sheet at 31 December 2004

  UK GAAP
as published
£m
  Adjustments
£m
IFRS
£m
Assets      
Goodwill 1,135 49 1,184
Acquired value of in-force business and intangible assets 451 65 516
Investments in joint ventures and associates 2,088 40 2,128
Property and equipment 283 529 812
Investment property 9,407 1,650 11,057
Financial investments and loans 140,763 47,648 188,411
Assets held to cover linked liabilities 51,144 (51,144)
Reinsurance assets 7,540 963 8,503
Tax assets 63 845 908
Other assets 16,275 (3,270) 13,005
Cash and cash equivalents 3,121 9,658 12,779
Total assets 232,270 7,033 239,303
Equity      
Share Capital 1,760 1,760
Capital reserves 3,878 3,878
Revaluation and other reserves 736 736
Retained earnings 2,682 (973) 1,709
Equity attributable to shareholders of Aviva plc 8,320 (237) 8,083
Minority interests 924 (14) 910
Total equity 9,244 (251) 8,993
Liabilities      
Insurance liabilities 195,591 (71,469) 124,122
Liability for investment contracts 69,555 69,555
Unallocated divisible surplus 9,218 (1,669) 7,549
Net asset value attributable to unitholders 2,247 2,247
Provisions 340 1,785 2,125
Tax liabilities 1,617 848 2,465
Borrowings (including subordinated debt) 4,560 5,530 10,090
Other liabilities 11,700 457 12,157
Total liabilities 223,026 7,284 230,310
Total equity and liabilities 232,270 7,033   239,303

Analysis of adjustments to the balance sheet at 31 December 2004 as a result of the transition to IFRS

  Investment
valuation
(note 1)
£m
Insurance
changes
(note 2)
£m
Employee
benefits
(note 3)
£m
Goodwill
(note 4)
£m
Dividend
recognition
(note 5)
£m
Deferred tax
(note 6)
£m
Borrowings/
cash
(note 7)
£m
FRS
(note 8)
£m
Other
items
(note 9)
£m
Total
£m
Assets                    
Goodwill       49         49
Acquired value of in-force business and intangible assets       65         65
Investments in joint ventures and associates 8     15         17 40
Property and equipment                 529 529
Investment property                 1,650 1,650
Financial investments and loans 2,599           (3,598)   48,647 47,648
Assets held to cover linked liabilities                 (51,144) (51,144)
Reinsurance assets   (108)           417 654 963
Tax assets           845     845
Other assets   (19) (475)         (13) (2,763) (3,270)
Cash and cash equivalents             8,792   866 9,658
Total assets 2,607 (127) (475) 129 845 5,194 404 (1,544) 7,033
Equity                    
Share capital                
Capital reserves                
Revaluation and other reserves 736               736
Retained earnings (452) 166 (909) 129 364 (322) (26) 77 (973)
Equity attributable to shareholders of Aviva plc 284 166 (909) 129 364 (322) (26)   77 (237)
Minority interests                 (14) (14)
Total equity 284 166 (909) 129 364 (322) (26)   63 (251)
Liabilities                    
Insurance liabilities 250 (69,797) (813)     28   4,226 (5,363) (71,469)
Liability for investment contracts   69,555               69,555
Unallocated divisible surplus 2,073 (165)       (62) 17 (3,822) 290 (1,669)
Net asset value attributable to unitholders                 2,247 2,247
Provisions     1,643           142 1,785
Tax liabilities     (396)     1,201 (4)   47 848
Borrowings (including subordinated debt)             5,207   323 5,530
Other liabilities   114     (364)       707 457
Total liabilities 2,323 (293) 434 (364) 1,167 5,220 404 (1,607) 7,284
Total equity and liabilities 2,607 (127) (475) 129 845 5,194 404 (1,544) 7,033

Note references are to section (iii)

(iii) Notes to the analysis of adjustments to the balance sheets as at 1 January and 31 December 2004 as a result of the transition to IFRS

The UK GAAP balance sheet has been presented in a format consistent with IFRS.

The only significant change in heading is that the Fund for Future Appropriations is now renamed the Unallocated Divisible Surplus.

The basis for the material adjustments between UK GAAP and IFRS is as follows:

(1) Investment valuation
The adjustments in respect of investment valuation arise from the following:

  1 January
2004
£m
  31 December
2004
£m
Increase in valuation of debt securities 1,718 2,459
Change in valuation of certain mortgages 113 119
Other sundry adjustments 23 21
  1,854 2,599

The principal changes are discussed further below:

a) Debt securities Under UK GAAP, equity securities and unit trusts are carried at current value. Debt and other fixed income securities are carried at current value, with the exception of many non-linked long-term business debt securities and fixed income securities, which are carried at amortised cost.

As a result of applying IAS 39, the Group now carries all investments in debt and equity securities at fair value. The change in valuation of debt securities from amortised cost to fair value increases the valuation of investments by £1,718 million at 1 January 2004 and £2,459 million at 31 December 2004. This change in the valuation of debt securities is largely offset by corresponding movements in the unallocated divisible surplus and technical liabilities. The net impact on shareholders’ funds at 1 January 2004 and 31 December 2004 is to increase them by £191 million and £284 million respectively.

b) Commercial mortgages backing certain annuity business Under IFRS, the Group has chosen to move certain of its commercial mortgage portfolio to an active fair valuation basis in accordance with IAS39, which has increased the value of investments by £113 million at 1 January 2004 and £119 million at 31 December 2004. The annuity liabilities which are backed by these assets have been correspondingly revalued, with the result that there is an insignificant impact on shareholders’ funds at either date.

c) Revaluation reserve Under IFRS, certain investment gains are recorded as a separate component of shareholders’ equity, whereas under UK GAAP they would be included in retained earnings.

Separate revaluation reserves are created for:

  • Changes in the fair value of securities classified as available for sale;
  • Changes in the value of owner-occupied property;
  • Exchange differences arising from the translation of the net investment in foreign subsidiaries, associates and joint ventures and from borrowings designated as hedges of such items; and
  • Changes in the fair value of derivatives that are designated and qualify as cash flow hedges.

The amounts included in the above reserves are, where appropriate, net of deferred tax and impairment losses.

The above requirements have resulted in transfers from retained earnings into separate revaluation reserves of £543 million and £736 million at 1 January 2004 and 31 December 2004 respectively.

(2) Insurance changes
The impact on shareholders’ funds of insurance changes is as follows:

  1 January
2004
£m
  31 December
2004
£m
Derecognition of claims equalisation provision 364 388
Change in the value of reinsurance treaties (48) (34)
Application of an active liability valuation basis in the Netherlands (7) (52)
Change in value of non-participating investment contracts and other sundry items (67) (136)
  242 166

The principal changes to the Group’s insurance accounting upon transition to IFRS are discussed further below.

a) Product classification IFRS 4, Insurance Contracts, requires all products issued to be classified for accounting purposes as either insurance or investment contracts, depending on whether significant insurance risk exists. In the case of a life contract, insurance risk exists if the amount payable on death differs from the amount payable if the policyholder survives. The Group has deemed insurance risk to be significant if the difference exceeds 5% of the policy value, although the classification would be similar if a 10% test had been used.

Following a detailed review, 61% of life policy reserves on an modified statutory solvency basis (MSSB) at 31 December 2003 (31 December 2004: 59%) have been classified as insurance and 24% (at both dates) have been classified as participating investment contracts (being those investment contracts containing a discretionary participating feature as defined within IFRS 4). Both classes will continue to be accounted for under the Group’s existing accounting policies. The remaining 15% (31 December 2004: 17%) have been classified as non-participating investment contracts and therefore are required to be accounted for under IAS 39 and IAS 18, Revenue. Virtually all our general insurance products are classified as insurance.

This product classification change has led to technical provisions being allocated between insurance and investment contracts. This has resulted in £57,445 million and £69,555 million of liabilities at 1 January 2004 and 31 December 2004 respectively being classified as investment contracts.

b) Equalisation provision An equalisation provision is recorded in the balance sheets of individual general insurance companies in the United Kingdom and in a limited number of other countries, to eliminate or reduce the volatility in incurred claims arising from exceptional levels of claims in certain classes of business. The provision is required by law even though no actual liability exists at the balance sheet date and is included in the UK GAAP consolidated balance sheet. The annual change in the equalisation provision is recorded in the UK GAAP profit and loss account. Under IFRS, no equalisation provision is recorded, as no actual liability exists at the balance sheet date. There are increases of £364 million and £388 million in shareholders’ funds at 1 January 2004 and 31 December 2004 respectively as a result of the removal of this provision.

c) Reinsurance treaties Following a full review of all our reinsurance contracts, a small number of the Group’s long-term reinsurance treaties have been revalued under IFRS, leading to reductions in the value of reinsurance assets of £134 million and £108 million at 1 January 2004 and 31 December 2004 respectively. The majority of these changes relate to participating contracts and so these value changes principally affect the unallocated divisible surplus rather than shareholders’ funds.

d) Application of an active liability valuation basis in the Netherlands The conversion to IFRS has been a particular issue in the Dutch industry where, traditionally, both bond investments and associated insurance liabilities have been held at amortised cost. IAS 39 requires bonds to be held at fair value and hence, to prevent an equity mis-match, the Group has chosen to move to a more active liability valuation basis for its insurance liabilities within the Netherlands. As a result of this change, gross liabilities increased by £41 million and £213 million at 1 January 2004 and 31 December 2004 respectively.

Having applied an active basis for valuing liabilities on a traditional gross and individual savings business, the amounts representing undistributed gains on investments backing these products which were previously booked to the fund for future appropriations under UK GAAP of £34 million at 1 January 2004 and £161 million at 31 December 2004 have been released to equity.

e) Non-participating investment contracts and other sundry items The liability for those contracts classified as non-participating investment contracts is valued in accordance with IAS 39. The majority of the Group’s contracts classified as non-participating investment contracts are unit-linked contracts and have been valued at fair value. For unit-linked contracts, the fair value liability is deemed to equal the current unit fund value, plus positive non-unit reserves if required on a fair value basis. This replaces the reserve held under UK GAAP which equals the unit fund value plus any positive or negative non-unit reserves determined on the local valuation basis, and which differs from that required on a fair value basis.

In addition to the change in liability valuation, the accounting for deferred acquisition costs has been revised in accordance with IAS 18. This restricts the types of acquisition costs that can be deferred, leading to a reduction in deferred acquisition costs as compared to UK GAAP.

The net impact on shareholders’ funds of the above changes and of other sundry items is a reduction of £67 million at 1 January 2004 and of £136 million at 31 December 2004.

In addition to the above, IFRS now requires that any front end fees received on non-participating investment contracts are included within an explicit deferred income reserve within creditors. Under UK GAAP, any deferred acquisition cost asset created would have been net of these fees. This has led to increases in “Other assets” and “Other liabilities” of £100 million and £114 million at 1 January 2004 and 31 December 2004 respectively.

(3) Employee benefits
a) Pensions Under the Group’s UK GAAP pension policy, as set out in Statement of Standard Accounting Practice 24, Accounting for Pension Costs (SSAP 24), the cost of providing pension benefits is expensed using actuarial valuation methods which give a substantially even charge over the expected service lives of employees, and results in either a prepayment or an accrual to the extent that this charge does not equate to the cash contributions made into the schemes. Under IAS 19, Employee Benefits, the projected benefit obligation is matched against the fair value of the underlying assets and other unrecognised actuarial gains and losses in determining the pension expense for the year. Any pension asset or obligation must be recorded in the balance sheet. Aviva has not applied the “corridor approach” to valuing pension deficits.

This change in accounting has resulted in the removal of the Group’s SSAP 24 balances, a net debtor of £251 million after allowing for deferred tax, at 1 January 2004 (31 December 2004: £279 million) and the recognition of a deficit of £583 million (31 December 2004: £630 million), net of deferred tax, valued in accordance with IAS 19. This gives an overall impact on shareholders’ funds of £834 million at 1 January 2004 and £909 million at 31 December 2004.

The Group has assumed that substantially all of the pension deficit will fall to be borne by the shareholders. This is particularly relevant to the UK pension scheme deficit, which forms the majority of the deficit recognised by the Group. Costs, including pension costs, are charged to the UK Life companies and with-profit funds on the basis of a pre-determined Management Services Agreement (MSA). As reported at the time of the conversion to EEV, where similar assumptions have been made in connection with deficit funding, under the MSA, NU Life Services Limited can renegotiate the terms relating to the recharging of the costs to the UK with-profit fund in 2008, subject to regulatory approval. In evaluating the impact on IFRS, Aviva has not sought to pre-empt the outcome of this renegotiation. Any changes to the recharges in respect of the pension deficit will be credited to equity in the period agreement is obtained.

In some countries, the pension schemes have invested in the Group’s long-term business funds. IAS 19 requires the liquidity of the schemes’ assets to be considered and, if these are deemed non-transferable, the presentation of the total obligation to the schemes must include these amounts. Accordingly, insurance liabilities have been reduced by £715 million at 1 January 2004 (£813 million at 31 December 2004) and provisions increased by the same amounts, to reflect this disclosure. There is no impact on equity or income arising from this presentation.

There are a number of adjustments impacting the Group’s “Provisions” line. However, the most significant adjustment relates to the recognition of the pension obligations as shown in the table below:

  1 January
2004
£m
  31 December
2004
£m
Provisions as stated under UK GAAP 336 340
Less: SSAP 24 pension obligation (78) (63)
Deficit in the staff pension schemes 838 893
Other obligations to staff pension schemes – insurance policies issued by Group companies 715 813
Total IAS 19 obligations to staff pension schemes 1,553 1,706
Adjustments to other provisions arising under IFRS 111 142
Provisions as stated under IFRS 1,922 2,125

b) Equity compensation plans Under UK GAAP, the costs of awards to employees under equity compensation plans, other than the Save As You Earn plans, are recognised immediately if they are not conditional on performance criteria. If the award is conditional upon future performance criteria, the cost is recognised over the period to which the employee’s service relates. The minimum cost for the award is the difference between the fair value of the shares at the date of grant less any contribution required from employee or exercise price. The cost is based on a reasonable expectation of the extent that the performance criteria will be met. Any subsequent changes in that expectation are reflected in the income statement as necessary.

Under IFRS 2, Share-based Payment, compensation costs for equity compensation plans that were granted after 7 November 2002, but had not yet vested at 1 January 2005, are determined based on the fair value of the share-based compensation at grant date, which is recognised in the income statement over the period of the expected life of the share-based instrument.

This change in accounting has not resulted in any material changes to the balance sheets at 1 January 2004 or 31 December 2004.

(4) Goodwill and intangibles
Under UK GAAP, goodwill arising before 1 January 1998 was eliminated against shareholders’ funds and was not subsequently reinstated. Goodwill previously written off to shareholders’ funds is taken back through the profit and loss account when calculating the profit or loss in the event of any subsequent disposal of the underlying investment. Under UK GAAP for acquisitions subsequent to 1997, goodwill arising on acquisition is carried on the balance sheet and amortised in the consolidated profit and loss account on a straight-line basis over its useful economic life, not exceeding 20 years.

Under IAS 36, Impairment of Assets, goodwill is no longer amortised but is tested for impairment at least annually. Any goodwill previously amortised prior to the date of transition (1 January 2004) or, for goodwill arising before 1 January 1998, eliminated against shareholders’ funds has not been reinstated. Amortisation charged in 2004 under UK GAAP is not charged to profit under IFRS to the extent that it does not relate to an impairment, and hence shareholders’ funds increase upon conversion to IFRS. In addition, negative goodwill of £40 million at 1 January 2004 and £37 million at 31 December 2004, previously recognised under UK GAAP, is included directly in retained earnings.

IFRS 3, Business combinations, requires that intangible assets such as customer lists, which can be separately identified and valued, must be recognised separately in the balance sheet. The Group has applied IFRS 3 to acquisitions since 1 January 2004, which has resulted in £65 million of goodwill being reclassified as intangibles upon conversion to IFRS.

(5) Dividend recognition
Under UK GAAP, dividends are accrued in the period to which they relate, regardless of when they are declared and approved.
Under IAS 10, Events after the Balance Sheet Date, shareholders’ dividends are accrued only when declared and appropriately approved. This has increased shareholders’ funds by £344 million at 1 January 2004 and £364 million at 31 December 2004.

(6) Deferred tax
Under UK GAAP, provision is made for deferred tax assets and liabilities, using the liability method, arising from timing differences between the recognition of gains and losses in the financial statements and their recognition in a tax computation. No provision is made for tax that might arise on undistributed earnings of subsidiaries unless a binding arrangement for distribution exists. Deferred tax is recognised as a liability or asset if the transactions or events that give the entity an obligation to pay more tax in future or a right to pay less tax in future have occurred by the balance sheet date. The Group policy is to discount its deferred tax balances.

Under IAS 12, Income tax, deferred tax is provided under the liability method for all relevant temporary differences, being the difference between the carrying amount of an asset or liability in the balance sheet and its value for tax purposes. IAS 12 does not require all temporary differences to be provided for. In particular, the Group does not provide for deferred tax on undistributed earnings of subsidiaries where the Group is able to control the timing of the distribution and the temporary difference created is not expected to reverse in the foreseeable future. Deferred tax assets are recognised for unused tax losses and other deductible temporary differences to the extent that it is probable that future taxable profit will be utilised against the unused tax losses and credits. Discounting is prohibited under IAS 12.

The changes to deferred tax arise from the removal of discounting, changes to the valuation of the Group’s assets and liabilities under IFRS and presentational changes to disclosure of tax assets and liabilities. The main net increases in deferred tax that reduce shareholders’ funds are:

  1 January
2004
£m
  31 December
2004
£m
Reversal of discounting (the total discounting applied to UK GAAP deferred tax liabilities at 1 January 2004 was £151 million (31 December 2004: £277 million), of which £110 million (31 December 2004: £215 million) relates to non-life and shareholders’ interests) 110 215
Deferred tax impact of the removal of the equalisation provision 108 117
Deferred tax impact of other changes to technical provisions, valuation of investments and other sundry adjustments 133 (10)
Net decrease to shareholders’ funds 351 322

(7) Borrowings and cash
IFRS requires a number of presentational changes to borrowings and cash. The most significant change is that the linked presentation can no longer be adopted for the Group’s borrowing securitised on certain of its mortgage portfolios. This increases borrowings and investments by £3,143 million at 1 January 2004 and £5,110 million at 31 December 2004. The equity impact of £37 million at 1 January 2004 and £26 million at 31 December 2004 relates to the application of the fair value option to the mortgages of the UK equity release business, the loan notes which are securitised upon them and backing derivatives, which more appropriately reflects the commercial substance of this business. This has increased borrowings by £90 million at 1 January 2004 and £97 million at 31 December 2004. Additionally, £3,307 million of the Group’s investments at 1 January 2004 (31 December 2004: £8,792 million) meet the definition of cash equivalents and so have been reclassified to this heading in the consolidated balance sheets.

(8) FRS 27 Life Assurance
In December 2004, the UK’s Accounting Standards Board (ASB) issued Financial Reporting Standard 27, Life Assurance (FRS 27). In accordance with the Memorandum of Understanding (MoU) signed by the Group along with other major insurance companies, the Association of British Insurers (ABI) and the ASB, the Group has adopted FRS 27 in its 2004 IFRS balance sheet. FRS 27 requires insurance companies to measure their liabilities on with-profit business, on a “realistic basis” (ie the FSA’s definition of a “realistic” valuation). The use of the “realistic” basis to measure liabilities for with-profit business does not impact reported profits, as an offsetting adjustment is made to the unallocated divisible surplus.

(9) Other items
The other changes that arise as a result of the transition to IFRS are principally reclassifications and presentational changes. The total effect of the other changes to shareholders’ funds is £71 million at 1 January 2004 and £77 million at 31 December 2004.

(i) Assets held to cover linked liabilities of £40,665 million at 1 January 2004 and £51,144 million at 31 December 2004 are no longer disclosed in a single line but have been reported in the various asset classifications. Of this amount, assets of £3,343 million at 1 January 2004 and £4,965 million at 31 December 2004 have been netted off technical liabilities, reducing the gross assets and investment contract liabilities of the Group. There is no impact on profit or shareholders’ funds as a result of this change.

(ii) The assets and liabilities of the banking business are no longer disclosed entirely in “other debtors” and “other creditors” but have been reported in the appropriate balance sheet classifications.

(iii) Owner-occupied properties have been reclassified from “investment property” to property and equipment. We continue to hold these properties at fair value.

(iv) Mutual funds have been consolidated where these vehicles meet the definition of a subsidiary. This has resulted in an increase in gross assets of £1,606 million at 1 January 2004 and £2,247 million at 31 December 2004, representing the part of the funds owned by third parties. This third party interest is recorded in the line “net assets attributable to unitholders” within liabilities. The consolidation of mutual funds has no impact on shareholders’ funds or profit after tax.

(iv) Summarised consolidated pro forma operating profit statement for the year ended 31 December 2004

  UK
GAAP
£m
IFRS
  changes
£m
  Restated
for IFRS
changes
£m
LTIR
(note 6)
£m
  Restated
for IFRS
and LITR
changes
£m

Note references are to section (v).

1. Represents the application of deposit accounting for those contracts classified as non-participating investment contracts.
2. Calculated as operating profit net of tax, minorities and preference dividend over interim and final ordinary dividends declared in respect of the financial year.
Net premiums written (excluding associates)          
Life premiums 19,899 (6,357)1 13,542 13,542
General insurance and health 9,809 9,809 9,809
  29,708 (6,357) 23,351 23,351
Operating profit          
Long-term business 1,185 (69) 1,116 1,116
Fund management 43 (3) 40 40
General insurance and health business 1,384 (28) 1,356 (97) 1,259
Non-insurance operations (108) (13) (121) (121)
Corporate costs (178) (10) (188) (188)
Unallocated interest charges (465) (465) (465)
Unallocated income 28 28 28
Operating profit before tax attributable to shareholders’ profits 1,861 (95) 1,766 (97) 1,669
Amortisation/impairment of goodwill (120) 79 (41) (41)
Amortisation of acquired additional value of in-force long-term business and intangibles (126) 34 (92) (92)
Financial Services Compensation Scheme and other levies (49) (49) (49)
Short-term fluctuation in return on investments 131 (67) 64 97 161
Change in the equalisation provision (23) 23
Net loss on the disposal of subsidiaries and associates (136) 170 34 34
Exceptional costs for termination of operations (50) 10 (40) (40)
Profit before tax attributable to shareholders’ profits 1,488 154 1,642 1,642
Tax attributable to shareholders’ profits (355) 84 (271) (271)
Profit for the year 1,133 238 1,371 1,371
Attributable to:          
Equity shareholders of Aviva plc 1,057 218 1,275 1,275
Minority interests 76 20 96 96
Earnings per share based on operating profit after tax attributable to ordinary shareholders 57.2p   56.9p   53.9p
Earnings per share based on profit after tax attributable to ordinary shareholders 45.8p   55.5p   55.5p
Dividend cover2 2.25 times   2.23 times   2.11 times

Analysis of IFRS adjustments to the pro forma operating profit statement for the year ended 31 December 2004 as a result of the transition to IFRS

  Investment
valuation
(note 1)
£m
  Insurance
changes
(note 2)
£m
  Employee
benefits
(note 3)
£m
  Goodwill
(note 4)
£m
  Policyholder
tax
(note 5)
£m
  Other
items
Total
  adjustments
£m
Operating profit              
Long-term business 111 (77) (27)   (93) 17 (69)
Fund management     (3)       (3)
General insurance and health business   5 (33)       (28)
Non-insurance operations     (3)     (10) (13)
Corporate costs     (10)       (10)
Unallocated interest charges            
Unallocated income     28       28
Operating profit before tax attributable to shareholders 111 (72) (48) (93) 7 (95)
Amortisation/impairment of goodwill       79     79
Amortisation of AVIF and intangibles         37 (3) 34
Financial Services Compensation Scheme and other levies            
Short-term investment fluctuation (67)           (67)
Change in equalisation provision   23         23
Net loss on the disposal of subsidiaries and associates       169   1 170
Exceptional costs for termination of operations           10 10
Profit before tax attributable to shareholders’ profits 44 (49) (48) 248 (56) 15 154
Tax attributable to shareholders’ profits (7) 15 56 20 84
Profit for the year 44 (56) (33) 248 35 238

Note references are to section (v)

(v) Notes to the Analysis of adjustments to the pro forma operating profit statement for the year ended 31 December 2004 as a result of the transition to IFRS

(1) Investment valuation
The main investment valuation change upon conversion to IFRS is that assets, which are not classified as being held to maturity, are required to be held at fair value. Under UK GAAP, certain of the Group’s bonds were held at amortised cost. This change in valuation of debt securities resulted in a £2,459 million increase in the valuation of securities at 31 December 2004. Most of this change was offset by corresponding movements in the unallocated divisible surplus and technical liabilities. However, there was a residual uplift which resulted in a positive increase in the Group’s shareholders’ funds, and the year-on-year movement in respect of those investments classified as “at fair value through profit and loss account” is reported as an increased profit in the 2004 income statement.

In addition, changes to investment accounting have resulted in £67 million of investment gains being reclassified from short-term fluctuations to the life operating profit.

(2) Insurance changes
Insurance changes consist of:

  • The removal of the claims equalisation provision, improving profit before tax by £23 million but with no impact on operating profit;
  • The revaluation of liabilities and deferred acquisition costs on those contracts classified as non-participating investment contracts, reducing operating profit by £91 million;
  • The revaluation of certain life reinsurance treaties, increasing operating profit by £14 million;
  • Other sundry changes to our general insurance business reserves, increasing operating profit in 2004 by £5 million.

Of these changes, the most significant impact occurs on our UK Life business, where profit falls by £90 million as a result of the adoption of IAS 39. On the basis of 2004 gross written premiums, 44% of our total life business within the UK is classified as non-participating investment contracts and includes unit-linked bonds and unit-linked pension contracts. IAS 39 reduces the level of deferred acquisition costs that can be recognised, as well as requiring the removal from technical provisions of positive or negative non-unit reserves determined on the local valuation basis held over and above the unit fund value. The effect of these changes is that the profits on a non-participating investment contract will arise later in the contract term under IFRS than under UK GAAP.

The overall impact on annual profits arising from this accounting change is dependent upon levels of new business, product mixes, the ageing profile of the existing in-force business and reserving policies. Additional new business strain under IFRS would be expected to be mitigated by the emergence of higher IFRS basis profits of the in-force book of business. Until mid-2003, unit-linked bond business sold by Norwich Union in the UK contained a guaranteed minimum death benefit, and hence contained significant insurance risk, and accordingly, as permitted by IFRS Phase 1, the UK GAAP basis profit profile has been retained. After mid-2003, this benefit was removed and business written since this time has been classified as non-participating investment business. The existing in-force business is therefore small and profits are insufficient to offset the new business strain. A significant conversion effect on profit therefore arises.

This reduction in profit is no more than a timing adjustment. Aviva’s main value measure remains European embedded value and the profit arising on this basis is unaffected by this technical accounting change.

(3) Employee benefits
The overall impact of adopting IAS 19, Employee benefits, and IFRS 2, Share based compensation, has been to increase costs by £48 million in 2004. This partly reflects the fact that IAS 19 has used a more current actuarial valuation to measure the ongoing pension service cost. The charge under UK GAAP was based on the SSAP 24 valuation which, as disclosed in the 2004 Annual Report and Accounts, was last updated for financial reporting purposes in April 2002.

(4) Goodwill
Goodwill is no longer amortised under IFRS but is subject to annual impairment review. Impairment charges of £41 million were incurred in 2004, relating to sundry small overseas businesses, which had been fully reflected within the UK GAAP amortisation charge of £120 million. No additional impairment arose as a result of the transition to IFRS.

A further £169 million credit arises to profit before tax, as goodwill previously charged directly to reserves was deducted from profit upon disposal of subsidiaries under UK GAAP. Under IFRS no such deduction is required. This change has no impact on operating profit or shareholders’ funds.

(5) Policyholder tax
Operating profit before tax has fallen relative to the UK GAAP result by £93 million as a result of a change in the allocation of the tax charged to the life funds between policyholders and shareholders. This presentational change has no impact on operating profit after tax or the tax suffered by the life funds but merely represents how the tax charge is presented in the financial statements. The increase in tax costs charged to operating profit arises principally in the UK, but has been partly offset by a change in allocation in the Netherlands, where all tax is now deemed to be shareholder tax.

It is a feature of the UK tax regime that the tax attributable to life business operations is a single charge in respect of policyholder income and shareholder profits. Under UK GAAP, the difficulty of allocating this charge between policyholders and shareholders is generally acknowledged and hence, under UK GAAP, the total tax charge is deducted from life operating profit in the long-term technical account, the net result of which is then grossed up at the effective shareholder tax rate. Traditionally, Aviva has grossed up at 30% which represents its view of the long-term effective rate. We remain of the view that this will be the rate suffered by shareholders over the longer term.

Under IFRS, all taxation must be reported within the taxation line. The profit before this total tax would present a misleading picture of the Group’s profit as (i) much of the policyholder tax is in the with-profits funds where the unallocated divisible surplus is adjusted on a net of tax basis; (ii) the cost of policyholder tax is priced into the relevant products; and (iii) the level of tax will vary on an annual basis in line with the investment return on assets backing the long-term funds.

The UK industry has therefore agreed that it is appropriate to adopt an income statement presentation which depicts profit before tax attributable to the shareholders. This requires an allocation of the total tax charge between policyholders and shareholders, with the policyholder charge being offset against operating profit. There is no universal view on how this allocation should be performed. Aviva has taken the view that the IFRS conceptual framework does not permit companies to use notional allocation or gross-up methods. Instead, the allocation to policyholder tax should reflect the actual tax payable at policyholder rates, including deferred tax. Aviva has therefore developed a conceptual methodology to achieve this consistently year-on-year.

In 2004, the level of tax attributed to the shareholders was reduced by the following arrangement. The £1.5 billion of capital injected into the life funds on the demutualisation of Norwich Union in 1997 had the effect that future distributions up to that amount by Norwich Union Life and Pensions are treated as already having suffered some shareholder tax. In 2004, a substantial proportion of the company’s shareholders’ surplus was sheltered by this arrangement and this has the impact of lowering the actual tax paid at shareholder rates. This is a genuine benefit to shareholders and resulted in higher profit after tax. This tax benefit has a finite capacity and will at some point be exhausted, such that over the long-term there will be an increase in shareholder tax rates back towards 30%. The use of this capacity is dependent on the level of distributions made by Norwich Union Life & Pensions.

The impact of this is that operating profit before tax falls relative to the UK GAAP result, as the actual shareholder rate suffered in the UK in 2004 was lower than 30%.

It should be noted that, from an EEV perspective, an asset representing this tax benefit is already established and so 30% remains as an appropriate shareholder tax rate for this business.

(6) Longer-term investment return
The Group has chosen to revisit its longer-term investment return (LTIR) methodology from 2005 as part of a discretionary change not required by IFRS. In order to provide suitable trend analysis, the 2004 comparatives are presented in accordance with this new methodology. The key changes are as follows:

  • For properties and equity, we have applied lower start of year long-term rates of investment return consistent with those adopted for reporting life operating returns under EEV principles. This would have reduced operating profit in 2004 by £25 million;
  • For fixed income securities, we have included the amortisation of the premium or discount arising upon acquisition of a bond within our LTIR calculation. This would have reduced operating profit before tax by £72 million in 2004;
  • The LTIR is only being applied to general insurance and health business.

These changes have no effect on profit before tax.

(vi) Reconciliation of the cash flows reported under UK GAAP to cash flows reported under IFRS

Under UK GAAP, as amended by the ABI SORP for insurance companies, the consolidated statement of cash flows presents only the cash flows of general insurance business and shareholders’ funds. Cash flows of the long-term business, other than amounts transferred to shareholders, are not included in this statement. IAS 7, Cash Flow Statements, requires the cash flow statement to include cash flows from all activities of the Group, including the reconciliation of cash flows from operating activities to profit or loss reported in the income statement. Other differences arise between the UK cash flow statements and IFRS, mainly due to reclassification of items under IFRS.

For the year ended 31 December 2004, the only material differences between the cash flow statements prepared under the two bases were the inclusion of cash flows from the Group’s long-term businesses and from newly-consolidated securitisation vehicles and investment vehicles, together with changes arising from the different definitions of cash and cash equivalents under these bases.

2 – Exchange rates

The Group’s principal overseas operations are located within the Eurozone. The results and cash flows of these operations have been translated into sterling at an average rate for the year of 1 euro = £0.68 (2004: 1 euro = £0.68) and their assets and liabilities have been translated at the year-end rate of 1 euro = £0.69 (2004: 1 euro = £0.71).

Total foreign currency movements during 2005 resulted in a loss recognised in the income statement of £203 million (2004: £31 million gain).

3 – Subsidiaries

(a) Acquisitions

(i) RAC plc

On 4 May 2005, the Group acquired 100% of the share capital of RAC plc. The results of RAC plc’s operations have been included in the consolidated financial statements of the Group with effect from 4 May 2005, and contributed £15 million to the consolidated profit before tax.

  £m
Purchase cost  
Cash paid 566
Fair value of 88 million shares issued, based on their published price at date of exchange (average of £6.03 per share) 530
Costs attributable 17
Total 1,113

The issue of new shares in the Company in exchange for shares in RAC plc has attracted merger relief under section 131 of the Companies Act 1985. Of the £530 million above, £22 million has been credited to share capital (see note 27(b)) and £508 million has been credited to the merger reserve, increasing that reserve from £2,763 million to £3,271 million.

The assets and liabilities at the date of acquisition were:

   Book
value
£m
  Revaluation
of
Intangibles
£m
Pension
scheme
  valuation
£m
  Fair value
and
   accounting
policy
£m
Fair
  value
£m
Assets          
Intangible assets 59 333 392
Tax assets 58 (58)
Other assets 608 38 646
Total assets 725 333 (20) 1,038
Liabilities          
Provisions          
Pension deficit (257) (56) (313)
Other (8) (14) (22)
Tax liabilities (118) 17 83 (18)
Other liabilities (708) (3) (711)
Total liabilities (973) (118) (39) 66 (1,064)
Net assets acquired (248) 215 (39) 46 (26)
Goodwill (including £118 million arising from the creation of the deferred tax liability on intangibles)         1,139
Intangible assets         392
Total goodwill and intangible assets         1,531
Less: deferred tax liability         (118)
Total value of goodwill and intangible assets net of associated tax included on balance sheet     1,413

Separable intangible assets have been identified and valued by an independent third party at £392 million, using estimated post-tax cash flows and post-tax discount rates. The Group has assessed the useful economic lives of these intangibles, considering relevant factors such as usage of the asset, typical product life cycles, potential obsolescence, maintenance costs, the stability of the industry, competitive position, and the period of control over the assets. In the case of the RAC and BSM brands, it has been determined that the existing lives of the assets, their competitive position in and the stability of their respective markets indicate that the brands have indefinite useful lives, and thus no amortisation has been charged in the period since acquisition. Of the total £392 million, £260 million has been assessed as having an indefinite life, with the remaining £132 million, mainly contractual customer relationships, being amortised over nine to 22 years.

A deferred tax liability of £118 million has been provided against these intangible assets, resulting in an increase in residual goodwill by this amount. Although this liability has been recognised in accordance with IAS 12, and a proportion will be amortised to the income statement as the related intangible asset is amortised, this liability is only payable if the intangible asset is sold separately and this is not expected to happen.

The pension scheme valuation adjustment and associated deferred taxation represents the effect of aligning the assumptions of the RAC plc schemes to those of Aviva. The fair value of the RAC pension deficit at the date of acquisition amounted to £313 million (£219 million after deferred tax).

The residual goodwill of £1,139 million essentially represents synergies, both in increased revenues and in reduced costs, expected to arise in RAC plc and our UK general insurance business as a result of the acquisition.

£109 million of integration costs for the restructuring of the combined Norwich Union Insurance and RAC businesses has been included in the results to 31 December 2005.

(ii) Gresham Insurance Company Limited

On 31 March 2005, the Group acquired 100% of the share capital of Gresham Insurance Company Limited. The cash consideration including purchase costs was £75 million. The fair value of the net assets acquired, including intangibles of £14 million, was £75 million, giving rise to no goodwill on acquisition.

(iii) Solus Automotive Limited

On 11 May 2005, the Group acquired 100% of the share capital of Solus Automotive Limited. The cash consideration including purchase costs was £20 million, including £12 million of cash and £8 million of deferred consideration. The fair value of the net assets acquired was nil, giving rise to £20 million of goodwill on acquisition.

(iv) Unaudited pro forma combined revenues and profit

Shown below are unaudited pro forma figures for combined revenues and profit as though the acquisition date for all business combinations effected during the year had been 1 January 2005, after giving effect to purchase accounting adjustments and the elimination of intercompany transactions. The pro forma financial information is not necessarily indicative of the combined results that would have been attained had the acquisitions taken place at 1 January 2005, nor is it necessarily indicative of future results.

  2005
£m
Revenues (premiums and fee income) 27,842
Profit before tax attributable to shareholders 2,578

Of the above pre-tax profit, £21 million has arisen since acquisition.

(v) Non-adjusting post-balance sheet events:

Irish bancassurance agreement
On 22 November 2005, the Group announced a new bancassurance agreement in Ireland between its wholly-owned subsidiary Hibernian Group plc (“Hibernian”) and Allied Irish Banks plc (“AIB”). This will create a leading force in the Irish life and pensions market and bring further opportunities for growth in this market. The transaction completed on 27 January 2006, following the receipt of regulatory and European Commission approval.

Under the terms of the agreement, Hibernian Life Holdings Limited (HLH), the parent company of Hibernian Life & Pensions Limited, has acquired all the shares of Ark Life Assurance Company Limited (Ark Life) from AIB in exchange for a 24.99% stake in the enlarged HLH and a balancing cash payment of €195.4 million which also reflects the management of Ark Life funds by Hibernian Investment Managers Limited, part of the Group’s fund management business. A further deferred cash payment of up to €10 million is payable, subject to the fulfilment of certain performance criteria.

AIB calculate embedded value on a different basis to that used by the Group and, in particular, do not use EEV principles. In view of the very recent timing of completion, it is currently impractical to comply with the requirements of paragraph 67 of IFRS 3, Business Combinations, and to state with any certainty the fair values of the assets and liabilities acquired, and therefore to estimate the goodwill arising on this acquisition and the unrealised gain on disposal of the Group’s 24.99% interest in HLH.

The gain on disposal of this interest in HLH will be calculated in accordance with SIC 13, Jointly Controlled Entities – Non-Monetary Contributions by Venturers, and will be recognised in 2006.

Acquisition in Sri Lanka
On 1 February 2006, the Group acquired a 51% interest in Eagle Insurance Limited (Eagle), the third largest insurer in Sri Lanka, by buying a majority shareholding in Eagle’s immediate holding company, NDB Finance Lanka (Pvt) Limited, for cash of £15 million. At the same time, Eagle has entered into a bancassurance agreement with National Development Bank Limited (NDB), Sri Lanka’s biggest development bank and Eagle’s other major shareholder. In view of the very recent timing of completion, it is currently impractical to comply with the requirements of paragraph 67 of IFRS 3, Business Combinations, and to state with any certainty the fair values of the assets and liabilities acquired, and therefore to estimate the goodwill arising on this acquisition.

(b) Disposals of subsidiaries and associates
The profit on disposal was determined as follows:

  2005
£m
2004
£m
Proceeds from sale 421 327
Net assets sold (245) (293)
Transaction costs (23)
Profit on disposal before tax 153 34
Tax on profit on disposal (43)
Profit on disposal after tax 110 34

The profit/(loss) on the disposal of subsidiaries and associates comprises:

  2005
£m
2004
£m
General insurance businesses    
United Kingdom 10 28
France 6
Asia (see below) 122
Other small operations (22)
  110 34

(i) Sale of Asian general insurance businesses

During 2005, the Group completed the disposal of its Asian general insurance businesses to Mitsui Sumitomo Insurance (MSI) for a total of US$450 million in cash. Under the terms of the agreement, MSI acquired all of Aviva’s general insurance businesses in Asia. These comprised the general insurance business of Aviva Limited and the general insurance assets of Aviva Asia Pte Limited in Singapore; Aviva Insurance Berhad in Malaysia (including its branch in Brunei); Aviva Insurance (Thai) Company Limited in Thailand; PT Aviva Insurance in Indonesia; Dah Sing General Insurance Co Limited in Hong Kong; and Aviva’s branch operations in Hong Kong, the Philippines, Marianas, Macau and Taiwan. The transaction was achieved through share purchase of Aviva’s interests in joint venture operations, business purchase and asset purchase in Singapore, and transfer of Aviva’s general insurance branch operations in Hong Kong, the Philippines, Marianas, Macau and Taiwan.

The transaction completed in two phases. Phase I completed on 28 February 2005 and included all businesses above except for Malaysia, Indonesia, Macau, Marianas, Taiwan, Dah Sing and the Philippines. Phase II completed in December 2005, when the last of these businesses was sold, with the exception of Taiwan which completed in February 2006. Due to its immateriality, this last disposal has been treated as a 2005 transaction.

The total sale proceeds were fixed by reference to the net assets of the businesses as at 31 December 2003 and were not adjusted to reflect the results in the period from 1 January 2004 to completion. The Group therefore hedged its exposure to the sale proceeds of US$450 million through the purchase of foreign currency forward contracts. The Group did not bear any continuing operating risk from 31 December 2003.

The results of the Asian general insurance business have been consolidated with those of the Group’s ongoing operations until the completion of each transaction. Although the Group retained no economic interest in the operations of this business beyond 31 December 2003, the post-tax operating profits have been incorporated in the Group’s consolidated income statement from 1 January 2004 to the date of completion. This has been offset by a corresponding change to the final profit on sale. The total pre-tax profit on sale was £165 million (£122 million after tax) and is summarised below:

  2005
£m
Net assets as at 31 December 2003 60
Post-tax operating profit to disposal 14
Dividends paid (5)
Foreign exchange rate movement on net assets 4
Net assets at disposal 73
Proceeds 256
Less: Net assets (73)
Transaction costs (18)
Pre-tax profit on sale 165
Tax attributable to profit on sale (43)
Post-tax profit on sale 122

The net assets at disposal of £73 million, comprised financial investments (£220 million) and other assets (£95 million), less insurance liabilities (£207 million) and other liabilities (£35 million).

(ii) Other

In July 2005, the Group completed the sale of the business and certain operational assets and liabilities of Hyundai Cars (UK), which was acquired as part of the RAC group, to Hyundai Motor UK Limited for a total of £70 million. This sale did not give rise to any gain or loss.

In December 2005, the Group sold its commercial fleet business in Lex Transfleet Limited to Fraikin Limited for a total of £69 million, of which £10 million is deferred consideration. The Group acquired 50% of Lex Transfleet Limited with the RAC group, and this company became a wholly-owned subsidiary after the Group acquired the remaining 50% of its share capital in November 2005. The sale resulted in a gain of £5 million.

No other disposal is considered material for further disclosure.

(c) Operations classified as held for sale
The assets and liabilities of operations classified as held for sale as at 31 December 2005 were as follows:

  2005
£m
2004
£m
Intangible assets 9
Investments and property and equipment 320
Receivables and other financial assets 68
Deferred acquisition costs and other assets 40
Cash and cash equivalents 25
Total assets 462
Payables and financial liabilities (96)  
Other liabilities (49)
Total liabilities (145)
Net assets 317

In October 2005, the Group announced its decision to sell its 50% stake in Lex Vehicle Leasing (Holdings) Limited (LVL), a joint venture with HBOS, as a result of HBOS exercising an option under the JV shareholders agreement. LVL provides vehicle leasing, supply, management, maintenance and incident support for companies who outsource the day-to-day operations of their fleets, and was acquired as a part of the Group’s acquisition of RAC. Completion of the sale of the investment in LVL is expected in the second quarter of 2006 and so the relevant assets and liabilities have been classified as Held for Sale in the consolidated balance sheet.

At year end, the Group held for sale certain divisions of Manufacturer Support Services (MSS), part of the RAC group. The decision to sell is part of the Group’s wider strategy to integrate RAC and exit non-core operations. The divisions being sold primarily comprise Lex Transfleet Limited, Multipart Holdings Limited and Lex Commercials Limited, both wholly-owned subsidiaries, and Hyundai Car Finance Limited, an associate in which the Group holds 49.99%. Lex Transfleet is a provider of complex fleet solutions, Multipart Holdings provides logistics and aftermarket services to the automotive sector and Lex Commercials is a leading UK commercial vehicles dealership group, while Hyundai Car Finance Limited provides vehicle instalment finance and leasing. The disposal groups have also been treated as Held for Sale and are expected to be sold by the second quarter of 2006.

(d) Exceptional costs for termination of operations
In February 2004, the Group announced the closure of its UK national broker subsidiary, Hill House Hammond (HHH) together with the sale of its commercial business. The associated pre-tax costs of the closure of HHH were £40 million and relate to termination activities, including redundancy costs and closure provisions.

(e) Other information
Principal subsidiaries at 31 December 2005 are listed in the Aviva Group of companies section.

One of the Group’s wholly-owned subsidiaries, Delta Lloyd NV, is subject to the provisions of Dutch corporate law and particularly the Dutch “structure company” regime. Under this regime, Delta Lloyd operates under a Supervisory Board which has a duty to have regard to the interests of a wide variety of stakeholders. The Supervisory Board includes two Aviva Group representatives and is responsible for advising and supervising Delta Lloyd’s Executive Board. The shareholder is one of the most important stakeholders to whom the Supervisory Board has a duty.

4 – Segmental information

(a) Primary reporting format – business segments
(i) Reporting segments
The principal activity of the Group is financial services, which is managed using the following reportable segments: long-term business, fund management, general insurance and health.

Long-term business
Our long-term business comprises life insurance, long-term health and accident insurance, savings, pensions and annuity business written by our life insurance subsidiaries, including managed pension fund business and our share of the other life and related business written in our associates and joint ventures, as well as the equity release business written in the United Kingdom.

Fund management activities
Our fund management business invests policyholders’ and shareholders’ funds, provides investment management services for institutional pension fund mandates and manages a range of retail investment products, including investment funds, unit trusts, OEICs and ISAs. Clients include Aviva Group businesses and third-party financial institutions, pension funds, public sector organisations, investment professionals and private investors.

General insurance and health
Our general insurance and health business provides insurance cover to individuals and to small and medium-sized businesses, for risks associated mainly with motor vehicles, property and liability, such as employers’ liability and professional indemnity liability, and medical expenses.

Other
Other activities not related to the core business segments or which are not reportable segments due to their immateriality, such as the RAC non-insurance operations, our banking businesses and service companies, are included as “Other”, in the following tables. Head office expenses, such as Group treasury and finance functions are also reported as “Other”, together with eliminations and other reconciling items. Certain financing costs and taxes are not allocated among the segments.

The accounting policies of the segments are the same as those for the Group as a whole. Any transactions between the business segments are on normal commercial terms and market conditions.

Segment assets and liabilities comprise operating assets and liabilities, being the majority of the balance sheet but excluding items such as tax and borrowings.

(ii) Segmental results – business segments

For the year ended 31 December 2005 Long-term
  business
£m
Fund
  management
£m
General
  insurance
and
health
£m
  Other
£m
  Total
£m
Gross written premiums 15,282 11,017 26,299
Premiums ceded to reinsurers (611) (706) (1,317)
Net written premiums 14,671 10,311 24,982
Change in unearned premium reserve (123) (123)
Net earned premiums 14,671 10,188 24,859
Fee and commission income 598 264 214 771 1,847
  15,269 264 10,402 771 26,706
Net investment income 21,985 11 1,603 123 23,722
Inter-segment revenue 112 112
Other income (10) 41 122 153
Segment income 37,244 387 12,046 1,016 50,693
Claims and benefits paid, net of recoveries from reinsurers (13,482) (6,224) (19,706)
Change in insurance liabilities, net of reinsurance (10,004) (372) (10,376)
Change in investment contract provisions (7,814) (7,814)
Change in unallocated divisible surplus (1,474) (1,474)
Fee and commission expense (1,481) (55) (2,752) (38) (4,326)
Other operating expenses          
Depreciation (11) (6) (17) (78) (112)
Amortisation of acquired value of in force business (45) (45)
Amortisation of intangible assets (18) (5) (16) (39)
Net impairment of acquired value of in force business (28) (28)
Net impairment of intangible assets (6) (6)
Impairment of goodwill (14) (29) (43)
Other net impairment losses recognised in the income statement (37) (37)
Inter-segment expenses (103) (9) (112)
Other expenses (999) (233) (615) (1,027) (2,874)
Finance costs (203) (58) (100) (361)
Segment expenses (35,719) (294) (10,052) (1,288) (47,353)
Segment result before share of profit/(loss) of joint ventures and associates 1,525 93 1,994 (272) 3,340
Share of profit/(loss) of joint ventures and associates 340 (1) 1 18 358
Segment result before tax 1,865 92 1,995 (254) 3,698
Unallocated costs          
Finance costs on central borrowings (see below)         (248)
Tax attributable to policyholders’ returns         (922)
Tax attributable to shareholders’ profits         (630)
Profit for the year         1,898

Finance costs on central borrowing comprise interest payable on borrowings by holding companies within the Group which is not allocated to operating companies.

Impairment losses, and reversal of such losses, recognised directly in equity were £nil and £124 million respectively in long-term business.

Pro forma reconciliation to operating profit before tax attributable to shareholders' profits

For the year ended 31 December 2005   Long-term
business
£m
Fund
  management
£m
General
  insurance
and
health
£m
  Other
£m
  Total
£m
Segment result before tax 1,865 92 1,995 (254) 3,698
Finance costs on central borrowings       (248) (248)
Adjusted for the following items          
Impairment of goodwill 14 29 43
Amortisation and impairment of acquired value of in-force business 73 73
Amortisation and impairment of intangibles 24 5 16 45
Short-term fluctuation in return on investments backing general insurance and health business (517) (517)
(Profit)/loss on the disposal of subsidiaries and associates 10 (41) (122) (153)
Integration costs 77 32 109
Unallocated interest (1) 25 (24)
Corporate costs reallocation 1 1 7 (9)
  1,987 92 1,551 (580) 3,050
Less:          
Tax attributable to policyholders’ returns (922) (922)
Operating profit before tax attributable to shareholders’ profits 1,065 92 1,551 (580) 2,128
For the year ended 31 December 2004   Long-term
business
£m
Fund
  management
£m
General
  insurance
and
health
£m
  Other
£m
  Total
£m
Gross written premiums 14,216 10,562 24,778
Premiums ceded to reinsurers (683) (744) (1,427)
Net written premiums 13,533 9,818 23,351
Change in unearned premium reserve (176) (176)
Net earned premiums 13,533 9,642 23,175
Fee and commission income 534 203 197 334 1,268
  14,067 203 9,839 334 24,443
Net investment income 14,503 8 1,176 46 15,733
Inter-segment revenue 114 114
Other income 13 21 34
Segment income 28,570 325 11,028 401 40,324
Claims and benefits paid, net of recoveries from reinsurers (12,015) (5,784) (17,799)
Change in insurance liabilities, net of reinsurance (5,393) (711) (6,104)
Change in investment contract provisions (5,635) (5,635)
Change in unallocated divisible surplus (1,330) (1,330)
Fee and commission expense (1,865) (70) (2,482) (54) (4,471)
Other operating expenses          
Depreciation (14) (4) (19) (60) (97)
Amortisation of acquired value of in force business (72) (72)
Amortisation of intangible assets
Net impairment of acquired value of in force business (13) (13)
Amortisation of other intangible assets (7) (7)
Impairment of goodwill on subsidiaries (18) (2) (21) (41)
Net impairment of property and equipment (1)     (24) (25)
Net impairment of other financial assets (3) (3)
Other reversal of impairment losses recognised in the income statement          
Inter-segment expenses (105) (9) (114)
Other expenses (788) (218) (610) (692) (2,308)
Finance costs (161) (43) (72) (276)
Segment expenses (27,420) (292) (9,660) (923) (38,295)
Segment result before share of profit/(loss) of joint ventures and associates 1,150 33 1,368 (522) 2,029
Share of profit/(loss) of joint ventures and associates 235 (6) 13 242
Segment result before tax 1,385 27 1,368 (509) 2,271
Unallocated costs          
Finance costs on central borrowings (see below)         (246)
Tax attributable to policyholders’ returns         (383)
Tax attributable to shareholders’ profits         (271)
Profit/(loss) for the year         1,371

Finance costs on central borrowings comprise interest payable on borrowings by holding companies within the Group which is not allocated to operating companies.

Impairment losses, and reversal of such losses, recognised directly in equity were £nil and £138 million respectively in long-term business.

Pro forma reconciliation to operating profit before tax attributable to shareholders' profits

For the year ended 31 December 2004   Long-term
business
£m
Fund
  management
£m
General
  insurance
and
health
£m
  Other
£m
  Total
£m
Segment result before tax 1,385 27 1,368 (509) 2,271
Finance costs on central borrowings (246) (246)
Adjusted for the following items          
Impairment of goodwill 18 2 21 41
Amortisation and impairment of acquired value of in-force business 85 85
Amortisation and impairment of intangibles 7 7
Financial Services Compensation Scheme and other levies 9 40 49
           
Short-term fluctuation in return on investments backing general insurance and health business (161) (161)
Profit on the disposal of subsidiaries and associates (12) (22) (34)
Exceptional costs for termination of operations 40 40
Corporate costs reallocation 4 4 22 (30)
  1,499 40 1,259 (746) 2,052
Less:          
Tax attributable to policyholders’ returns (383) (383)
Operating profit before tax attributable to shareholders’ profits 1,116 40 1,259 (746) 1,669

(iii) Segmental balance sheet – business segments

As at 31 December 2005   Long-term
business
£m
Fund
  management
£m
General
  insurance
and
health
£m
  Other
£m
  Total
£m
Goodwill 631 398 1,245 2,274
Acquired value of in-force business and intangible assets 424 265 114 803
Investments in joint ventures and associates 2,815 46 39 114 3,014
Property and equipment 367 4 126 388 885
Investment property 12,895 338 42 13,275
Loans 18,240 3,661 2,643 24,544
Financial investments 166,211 22 12,496 3,659 182,388
Other assets 23,185 436 9,425 2,113 35,159
Segment assets 224,768 508 26,748 10,318 262,342
Unallocated assets – tax assets         1,105
Total assets         263,447
Insurance liabilities 114,176 18,426 132,602
Liability for investment contracts 77,309 77,309
Unallocated divisible surplus 8,978 8,978
Net asset value attributable to unitholders 3,137 3,137
External borrowings 4,060 2,565 578 7,203
Other liabilities, including inter-segment liabilities 6,149 278 (224) 9,622 15,825
Segment liabilities 213,809 278 20,767 10,200 245,054
Unallocated liabilities          
Central borrowings (see below)         3,810
Tax liabilities         3,491
Total liabilities         252,355
Total equity         11,092
Total equity and liabilities         263,447
Capital expenditure          
Intangible assets 44 6 2 52
Property and equipment 26 3 11 166 206
  70 3 17 168 258

Central borrowings are borrowings by holding companies within the Group which are not allocated to operating companies.

As at 31 December 2004   Long-term
business
£m
Fund
  management
£m
General
  insurance
and
health
£m
  Other
£m
  Total
£m
Goodwill 595 308 281 1,184
Acquired value of in-force business and intangible assets 451 19 46 516
Investments in joint ventures and associates 1,995 40 13 80 2,128
Property and equipment 404 7 133 268 812
Investment property 10,639 362 56 11,057
Loans 17,090 2,635 2,330 22,055
Financial investments          
Debt securities 86,897 2 9,255 2,565 98,719
Equity securities 44,269 1 2,449 572 47,291
Other investments 20,067 6 224 49 20,346
Other assets 23,455 311 9,786 735 34,287
Segment assets 205,862 367 25,184 6,982 238,395
Unallocated assets – tax assets         908
Total assets         239,303
Insurance liabilities 106,329 17,793 124,122
Liability for investment contracts 69,555 69,555
Unallocated divisible surplus 7,549 7,549
Net asset value attributable to unitholders 2,247 2,247
External borrowings 4,082 1,439 270 5,791
Other liabilities, including inter-segment liabilities 6,250 191 474 7,367 14,282
Segment liabilities 196,012 191 19,706 7,637 223,546
Unallocated liabilities          
Central borrowings (see below)         4,299
Tax liabilities         2,465
Total liabilities         230,310
Total equity         8,993
Total equity and liabilities         239,303
Capital expenditure          
Intangible assets 5 5
Property and equipment 27 3 12 173 215
  27 3 17 173 220

Central borrowings are borrowings by holding companies within the Group which are not allocated to operating companies.

(b) Secondary reporting format – geographical segments

(i) Reporting segments

Although the Group’s business segments are managed on a worldwide basis, they operate in five main geographical areas. These are United Kingdom, France, Netherlands (including Belgium and Luxembourg), Other Europe and International.

Revenue by destination does not differ materially from revenue by geographical origin, as most risks are located in the countries where the contracts were written.

(ii) Segmental results and balance sheets – geographical segments

Year ended 31 December 2005   United Kingdom
£m
  France
£m
 Netherlands
£m
  Other Europe
£m
  International
£m
Total
£m
Gross written premiums 11,510 4,250 3,878 4,316 2,345 26,299
Premiums ceded to reinsurers (914) 35 (22) (306) (110) (1,317)
Internal reinsurance revenue (10) (6) (4) (1) 21
Net written premiums 10,586 4,279 3,852 4,009 2,256 24,982
Fee and commission income 1,002 200 192 239 214 1,847
Segment revenue 11,588 4,479 4,044 4,248 2,470 26,829
Segment result before tax 2,057 304 348 461 553 3,723
Segment assets 136,235 46,682 38,871 29,868 11,791 263,447
Segment liabilities:            
External borrowings (2,128) (10) (5,013) (52) (7,203)
Other liabilities, including inter-segment liabilities (126,759) (44,274) (30,714) (26,387) (9,717) (237,851)
  (128,887) (44,284) (35,727) (26,439) (9,717) (245,054)
Segment net assets 7,348 2,398 3,144 3,429 2,074 18,393
Unallocated liabilities           (7,301)
Total net assets           (11,092)
Capital expenditure 167 5 31 32 23 258

 

Year ended 31 December 2004   United Kingdom
£m
  France
£m
 Netherlands
£m
  Other Europe
£m
  International
£m
Total
£m
Gross written premiums 11,449 3,625 3,231 4,274 2,199 24,778
Premiums ceded to reinsurers (945) (57) (86) (188) (151) (1,427)
Internal reinsurance revenue (21) (6) (4) 11 20
Net written premiums 10,483 3,562 3,141 4,097 2,068 23,351
Fee and commission income 620 193 187 164 104 1,268
Segment revenue 11,103 3,755 3,328 4,261 2,172 24,619
Segment result before tax 718 245 335 431 296 2,025
Segment assets 124,127 44,216 30,539 30,089 10,332 239,303
Segment liabilities:            
External borrowings (1,737) (21) (4,007) (21) (5) (5,791)
Other liabilities, including inter-segment liabilities (116,850) (41,866) (23,911) (26,832) (8,296) (217,755)
  (118,587) (41,887) (27,918) (26,853) (8,301) (223,546)
Segment net assets 5,540 2,329 2,621 3,236 2,031 15,757
Unallocated liabilities           (6,764)
Total net assets           8,993
Capital expenditure 110 1 88 17 4 220

 

(iii) Life and pensions and investment sales – new business and total income

For the purpose of recording life and pensions new business premiums, the Group’s policy is to include life insurance, long-term health and accident insurance, savings, pensions and annuity business written by our life insurance subsidiaries, including managed pension fund business and our share of the other life and related business written in our associates and joint ventures, as well as the equity release business written in the UK. This includes both insurance and investment contracts as defined under IFRS 4, Insurance Contracts, and is consistent with the definition of covered business used for our supplementary embedded value reporting.

An analysis of new long-term business sales is provided below. In this table, single premiums are those relating to products issued by the Group which provide for the payment of one premium only. Regular premiums are those where there is a contractual obligation to pay on an ongoing basis. Life and pensions total income represents all net written premiums in the year for insurance contracts and investment contracts, excluding non-participating investment contracts which are required to be accounted for under IAS 39, Financial Instruments: Recognition and Measurement, and IAS 18, Revenue.

  New single premiums   New regular premiums   Total income
2005
£m
2004
£m
  2005
£m
2004
£m
  2005
£m
2004
£m
Life and pensions:                
United Kingdom – Group companies 6,573 6,297   485 499   4,676 4,768
  – associates and joint ventures 205   17   319
  6,573 6,502   485 516   4,676 5,087
France 3,077 2,454   76 62   3,553 2,892
Netherlands 1,245 1,131   146 148   2,582 1,859
Other Europe                
Ireland 372 203   63 66   182 195
Italy 1,940 1,529   58 45   1,357 1,084
Poland 120 60   30 31   312 267
Spain 1,395 1,566   100 91   1,248 1,206
Other 406 336   80 90   152 565
International 798 660   113 105   870 706
Total life and pensions (including share of associates and joint ventures) 15,926  14,441   1,151  1,154   14,932  13,861
Retail sales of mutual fund type products:                
United Kingdom 1,139 840   21 19   1,160 859
Netherlands 563 196     563 196
Other Europe                
Poland 49 75   4 2   53 77
Other 410 254     410 254
International 213 243     213 243
Total investment sales 2,374 1,608   25 21   2,399 1,629
Total long term savings (including share of associates and joint ventures) 18,300  16,049   1,176  1,175   17,331  15,490

Included within new business sales is £5,071 million single premiums and £357 million regular premiums (2004: £4,338 million and £410 million respectively) in respect of contracts that meet the definition of “non-participating investment” contracts under IFRS 4, Insurance Contracts. Under IFRS, the premiums on these contracts are not included in the Group income statement under earned premiums, but are included on the balance sheet as a deposit.

5 – Details of income

  Note   2005
£m
2004
£m
Gross written premiums        
Long-term:        
Insurance contracts     9,916 10,038
Participating investment contracts     5,366 4,178
General insurance and health     11,017 10,562
  4a   26,299 24,778
Less: premiums ceded to reinsurers 4a    (1,317)  (1,427)
Gross change in provision for unearned premiums 35e   (216) (232)
Reinsurers’ share of change in provision for unearned premiums 36c   93 56
Net change in provision for unearned premiums     (123) (176)
Net premiums earned     24,859 23,175
Fee and commission income        
Fee income from investment contract business     288 349
Fund management fee income     274 176
Other fee income     921 211
Reinsurance commissions receivable     274 512
Other commission income     99 28
Net change in deferred revenue     (9) (8)
      1,847 1,268
Total revenue     26,706 24,443
Net investment income        
Interest and similar income     6,396 6,052
Dividend income     1,778 1,494
Other income from investments designated as trading        
Realised gains and losses     (78) (250)
Unrealised gains and losses     42 190
      (36) (60)
Other income from investments designated as other than trading        
Realised gains and losses     4,502 1,873
Unrealised gains and losses     8,771 4,007
      13,273 5,880
Realised gains and losses on AFS investments     154 322
Net income from investment properties        
Rent     747 728
Expenses relating to these properties     (19) (8)
Gains on disposal     41 89
Fair value gains on investment properties     1,571 1,154
Gains on loans     38 34
Foreign exchange gains and losses on investments other than trading     (207) 43
Other investment (expense)/income     (14) 5
Net investment income     23,722 15,733
Share of profit after tax of joint ventures 17   326 234
Share of profit after tax of associates 18   32 8
Share of profit after tax of joint ventures and associates     358 242
Profit on the disposal of subsidiaries and associates 3b   153 34
Total income     50,939  40,452

6 – Details of expenses

  Note   2005
£m
2004
£m
Claims and benefits paid        
Claims and benefits paid to policyholders on long-term business        
Insurance contracts     10,325 9,276
Participating investment contracts     2,465 3,114
Non-participating investment contracts     1,188 62
Claims and benefits paid to policyholders on general insurance and health business     6,523 6,131
      20,501  18,583
Less: Claim recoveries from reinsurers        
Insurance contracts     (697) (595)
Participating investment contracts     (50) (89)
Non-participating investment contracts     (48) (100)
Claims and benefits paid, net of recoveries from reinsurers     19,706 17,799
Change in insurance liabilities        
Change in insurance liabilities     9,673 6,434
Less: Change in reinsurance asset for insurance provisions     703 (330)
Change in insurance liabilities, net of reinsurance     10,376 6,104
Change in investment contract provisions        
Investment income allocated to investment contracts     3,633 2,192
Other changes in provisions        
Participating investment contracts     3,530 2,847
Non-participating investment contracts     69 596
Less: Change in reinsurance asset for investment contract provisions     582
      7,814 5,635
Change in unallocated divisible surplus     1,474 1,330
Fee and commission expense        
Acquisition costs        
Commission expenses for insurance and participating investment contracts     2,700 2,443
Change in deferred acquisition costs for insurance and participating investment contracts     (208) 340
Deferrable costs for non-participating investment contracts     165 134
Other acquisition costs     1,245 1,213
Changes in deferred acquisition costs for non-participating investment contracts     (258) (92)
Reinsurance commissions and other fee and commission expense     682 433
      4,326 4,471

 

  Note   2005
£m
2004
£m
Other operating expenses        
Staff costs and other employee-related expenditure 9   1,640 1,815
Global finance transformation programme     28 85
Other corporate costs     108 49
Depreciation 19   112 97
Impairment losses on property and equipment 19   25
Impairment of goodwill on subsidiaries 15   43 41
Amortisation of acquired value of in-force business 16 & 18   44 72
Amortisation of intangible assets 16   39 7
Impairment of acquired value of in-force business 16   29 13
Impairment of intangible assets 16   6
Integration costs     109
      2,158 2,204
Net impairments on loans 21   4 1
Net impairments on financial investments     5 1
Net impairments on receivables and other financial assets     10 1
Net impairments on non-financial assets     38
      57 3
Other net foreign exchange (gains)/losses     (4) 12
Other expenses     973 347
      3,184 2,566
Finance costs        
Interest expense on:        
Subordinated debt     169 169
Debenture loans     41 37
Amounts owed to credit institutions     37 10
Commercial paper     24 34
Securitised mortgage loan notes     183 174
Banking customer deposits     79 71
      533 495
Other similar charges     76 27
      609 522
Total expenses     47,489  38,427

7 – Analysis of investment return

(a) The total investment return reflected in profit before tax comprises:

  2005
£m
  2004
£m
Share of result after tax of joint ventures 326 234
Share of result after tax of associates 32 8
Net rental income from investment properties 728 720
Interest, dividend and similar income 8,174 7,546
Foreign exchange gains and losses on investments designated as at fair value through profit or loss (207) 43
Realised investment gains on financial investments, loans, investment property and owner occupied property 4,657 2,068
Net impairment losses on investments designated as available for sale and on loans (57) (3)
Other investment (expenses)/income (14) 5
Finance costs    
Allocated costs (361) (276)
Unallocated interest charges:    
Subordinated debt (169) (169)
Other borrowings (79) (77)
  (248) (246)
Investment return before unrealised gains 13,030 10,099
Unrealised investment gains on financial investments and loans designated as at fair value through profit or loss 10,384 5,351
Total investment return included in profit before tax 23,414  15,450

In addition to the investment return recognised above, £110 million of investment losses (2004: £64 million) has been recognised directly in equity as detailed in the statement of recognised income and expense.

(b) Effective interest rates

The table below summarises the average effective interest rate by major currency for monetary financial instruments:

  2005   2004
  Sterling
%
  Euro
%
  Can $
%
  Sterling
%
  Euro
%
  Can $
%
Monetary assets              
Loans 5.9 4.6 4.5   6.4 4.6 4.1
Debt securities 4.9 4.3 4.6   5.1 4.5 4.7
Other investments 4.0   4.5 4.3
Monetary liabilities              
Borrowings 6.3 5.4   6.2 4.8

The investment liabilities in relation to long-term business valued at amortised cost represent only 0.4% of the total liabilities relating to long-term business. On grounds of materiality, their effective interest rate has not been calculated.

8 – Longer term investment return

(a) The longer-term investment return, net of expenses, attributable to the general insurance and health business result was £1,046 million (2004: £988 million).

(b) The longer-term investment return and short-term fluctuation are as follows:

  General insurance and
health business
2005
£m
  2004
£m
Net investment income (note 4a) 1,603 1,176
Less: Internal charges reflected in other headings (40) (27)
  1,563 1,149
Longer term investment return 1,046 988
Short-term fluctuation in investment return 517 161
    1,563 1,149

(c) The longer term investment return is calculated separately for each principal general insurance and health business unit. In respect of equities and properties, the return is calculated by multiplying the opening market value of the investments, adjusted for sales and purchases during the year, by the longer term rate of investment return. The longer term rate of investment return is determined using consistent assumptions between operations, having regard to local economic and market forecasts of investment return. The allocated longer term return for other investments is the actual income receivable for the year.

(d) The principal assumptions underlying the calculation of the longer term investment return are:

  Longer term rates of return
Equities
  Longer term rates of return
Properties
2005
%
  2004
%
2005
%
  2004
%
United Kingdom 7.6% 7.8%   6.6% 6.8%
France 6.7% 7.3%   5.7% 6.3%
Netherlands 6.7% 7.3%   5.7% 6.3%
Ireland 6.7% 7.3%   5.7% 6.3%
Canada 7.4% 7.7%   6.4% 6.7%

For 2006, the Group intends to apply the same economic assumptions for equities and properties as are used under EEV principles to calculate the longer-term investment return for its general insurance and health business.

The above rates are consistent with the economic assumptions for equities and properties used under EEV principles.

(e) The table below compares the actual return on investments attributable to the general insurance and health business, after deducting investment management expenses and charges, with the aggregate longer term return over a two year period. This table will be built up over time to give aggregate and comparative figures over a five-year period.

    2004 – 2005
£m
Actual return attributable to shareholders 2,712
Longer term return credited to operating results (2,034)
Surplus of actual returns over longer term returns 678

(f) The table below shows the sensitivity of the Group’s general insurance and health operating profit before tax to changes in the longer term rates of return:

Movement in investment
return for
By Change in   2005
£m
 2004
£m
Equities 1% higher/lower  Group operating profit 29 25
Properties 1% higher/lower Group operating profit 4 3

9 – Employee information

The average number of persons employed by the Group during the year was:

  2005
Number
2004
  Number
United Kingdom 33,827 32,588
France 4,351 4,399
Netherlands 6,338 6,671
Other Europe 5,667 6,359
International 4,608 5,855
  54,791 55,872

Total staff costs were:

  2005
£m
2004
  £m
Wages and salaries 1,677 1,645
Social security costs 210 208
Post-retirement obligations    
Defined benefit schemes (note 42b) 158 158
Defined contribution schemes (note 42b) 47 47
Profit sharing and incentive plans 116 61
Equity compensation plans (notes 28d & 32) 22 21
Termination benefits 10 14
  2,240 2,154

These costs are charged within:

  2005
£m
  2004
£m
Acquisition costs 600 339
Other operating expenses 1,640 1,815
  2,240  2,154

10 – Directors

Information concerning individual directors’ emoluments, interests and transactions is given in the Directors’ Remuneration Report.

Top of page
Aviva plc Annual report and accounts 2005
Previous page""Next page